Traws Pharma, Inc. (TRAW) — Insider Trading

Key Insights

• The reporting person, Charles N. Parker, who is the Chief Financial Officer of Traws Pharma, Inc., has received a significant number of stock options and restricted stock units, indicating potential alignment of his interests with those of shareholders.
• The stock options and restricted stock units vest 100% on the first anniversary of the grant dates, suggesting the company is incentivizing long-term performance and retention of the CFO.
• The strike prices of the stock options ($3.01, $2.33, and $1.60) are lower than the current stock price, potentially providing the CFO with a financial incentive to drive stock price appreciation.